COLUMBIA, Md., March 26 /PRNewswire-FirstCall/ -- Renewable
fuels provider New Generation Biofuels Holdings, Inc. (Nasdaq:
NGBF) ("NGBF" or the "Company") today announced its financial
results for the fourth quarter and year ended December 31, 2009.
Fourth Quarter and Full Year 2009 Financial Results
New Generation Biofuels reported revenues of $101,890 and a net loss of $4.9 million for the three months ended
December 31, 2009 compared to net
revenues of $22,943 and a net loss of
$6.3 million for the three months
ended December 31, 2008.
Biofuel production and sales increased to 88,000 gallons in
the fourth quarter of 2009 compared to 14,000 gallons the fourth
quarter of 2008. Total operating expenses decreased by
approximately $2.0 million for the
three months ended December 31, 2009
compared to the same period in 2008. This decrease was
driven by an increase in cost of product revenue of approximately
$0.6 million offset by a decrease in
research and development expenses of approximately $0.1 million (both driven primarily by the
Company's growth from a development stage organization in 2008 to
commercial production and sale of biofuel in 2009), a decrease in
general and administrative expenses of approximately $0.9 million (resulting primarily from decreases
in legal and non-cash compensation expenses) and the absence of a
$1.6 million non-cash license
impairment charge that was recorded in the fourth quarter of 2008.
Total Loss from Operations decreased by approximately $2.1 million for fourth quarter of 2009 compared
to the prior year's fourth quarter.
For the full year 2009, the Company had net revenues of
$178,938 and a net loss of
$19.1 million. The Company was
still in the development stage during 2008, and for the full year
2008 had net revenues of $22,943 and
a net loss of $17.2 million.
Approximately 209,000 gallons of biofuel were produced in
2009 compared to 14,000 gallons in 2008. Total operating
expenses decreased by approximately $0.5
million for the full year 2009 compared to 2008. This
decrease was the net result of an increase in cost of product
revenue of approximately $2.0 million
offset by a decrease in research and development expenses of
approximately $0.6 million (both
driven primarily by the start of commercial operation 2009), and
the absence of a $1.6 million
non-cash license impairment charge and $0.4
million legal settlement that were both recorded in 2008.
Loss from Operations decreased by approximately $0.6 million for the full year 2009 compared to
2008.
The net change in the fair value of derivatives during 2009
compared to 2008 resulted in a non-cash loss of approximately
$1.7 million. This is primarily
the result of the change in fair value during 2009 of the
detachable warrants issued to investors in connection with several
financings during the year ended December
31, 2009.
As of December 31, 2009, the
Company had cash on hand of approximately $0.6 million. Net cash used in operating
activities was $7.1 million for the
full year ended December 31, 2009,
compared to $6.3 million in last
year's comparable period.
Full Year 2009 & Early 2010 Highlights
- Completed construction of first commercial-scale plant in
Baltimore with an initial 5
million gallons per year capacity.
- Completed 41 production runs at our Baltimore production facility through
December 2009.
- Produced approximately 209,000 gallons of our biofuel in
2009.
- Expanded our license agreement with PTJ Bioenergy Holdings
Ltd., or PTJ, the licensor of NGBF's renewable biofuel technology,
to capture a cross-licensing royalty equal 5% of PTJ's revenues
outside of our territory, which includes North America, Central America and the Caribbean and a 5% sales commission payable by
PTJ to us if we introduce PTJ to a potential customer or otherwise
substantially assist PTJ in the making of any sale outside of our
territory.
- Executed non-binding Letters of Intent (LOI) under which
businesses in Costa Rica,
Puerto Rico and Canada are evaluating licensing our technology
with the intent of constructing biofuel manufacturing facilities
and marketing NGBF biofuel. These LOIs contemplate payment to
NGBF of a fee per gallon of fuel produced and sold.
- Streamlined and reduced operating costs by moving our
headquarters to Columbia,
Maryland, closer to our biofuel production facility.
- Blended our biofuel with #6 Diesel fuel to diversify our
product applications and expand our potential markets.
- Entered into an agreement with Ferdinando Petrucci, a partner of PTJ and the
inventor of our proprietary technology, to issue 1,100,000 shares
of common stock and $120,000 in cash
in lieu of the $1 million license
payment payable in two equal installments in February and
March 2010 to help conserve cash and
strengthen our liquidity.
- Raised $7.9 million in gross
proceeds through three common stock equity offerings in 2009,
providing the Company with additional capital to fund our business
plans.
- In January 2010, Baltimore City Schools named us in their
annual heating fuel request for proposal. This request for proposal
by the Baltimore City Schools is
in conjunction with a proposed 1 year contract with the
City of Baltimore. We previously
completed a successful test program with the City of Baltimore and reached an agreement to
proceed with a longer contract to include the Baltimore City Schools.
- In February 2010, we closed a
private placement of common stock and warrants for total gross
proceeds of approximately $1.3
million.
- On March 12, 2010, we executed a
non-binding Memorandum of Understanding, or MOU, with Regent Trend
Investment Ltd (soon to be re-named Milestone Biofuels Limited, or
Milestone), a potential strategic partner from China, under which Milestone would invest
$20 million in our equity securities
and we would collaborate with Milestone to form a joint venture to
develop and operate biofuel production plants in the continental
United States with a total
aggregate plant capacity of 250 million gallons per year. Milestone
would fund all of the capital requirements for the joint venture
and we would provide the technology and operate the plants.
We would earn a minimum royalty on all sales from the joint venture
and would share in a percentage of profits above the minimum
royalty. The MOU remains subject to a due diligence period of up to
75 days and negotiation, execution and delivery of definitive
agreements acceptable to both parties and approved by their
respective boards of directors. The investment also may be subject
to shareholder approval under the NASDAQ listing rules. There is no
assurance that definitive agreements will be signed or that the
transaction will close.
"During 2009 New Generation Biofuels transitioned from a
development stage enterprise to a commercial business. I am
very pleased with the progress we have made in the execution of our
growth strategy both in the production and direct sale of our
biofuel and in pursuing technology sublicensing opportunities in an
extremely difficult capital market," said Cary J. Claiborne, President and Chief Executive
Officer of New Generation. "As we move forward in 2010 we need to
build on what we accomplished in 2009 and continue to execute our
business plan. I am looking forward to completing the steps
necessary to finalize our transaction with Milestone Biofuels
which, if it were to close, I believe would be a transformational
deal for our company."
About New Generation Biofuels, Holdings, Inc.
New Generation Biofuels is a renewable fuels provider. New
Generation Biofuels holds an exclusive license for North America, Central America and the Caribbean to commercialize proprietary
technology to manufacture alternative biofuels from plant oils and
animal fats that it markets as a new class of biofuel for power
generation, commercial and industrial heating and marine use. The
Company believes that its proprietary biofuel can provide a lower
cost, renewable alternative energy source with significantly lower
emissions than traditional fuels. New Generation Biofuels' business
model calls for establishing direct sales from manufacturing plants
that it may purchase or build and sublicensing its technology to
qualified licensees.
Forward Looking Statements
This news release contains forward-looking statements. These
forward-looking statements concern our operations, prospects,
plans, economic performance and financial condition and are based
largely on our current beliefs and expectations. These statements
involve known and unknown risks, uncertainties and other factors
that may cause actual results to be materially different from any
future results expressed or implied by such forward-looking
statements. The risks and uncertainties related to our business
include all the risks attendant a development stage business in the
volatile energy industry, including, without limitation, the risks
set forth under the caption "Risk Factors" in the Company's Annual
Report on Form 10-K for the fiscal year ended December 31, 2008 and in subsequent filings with
the Securities and Exchange Commission.
NEW GENERATION BIOFUELS HOLDINGS, INC.
Consolidated Balance Sheets
|
|
|
|
December 31, 2009
|
|
|
December 31, 2008
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
|
|
Cash
and cash equivalents
|
|
$
|
567,647
|
|
|
$
|
1,476,246
|
|
|
Accounts receivable
|
|
|
63,900
|
|
|
|
22,943
|
|
|
Other
receivables
|
|
|
41,406
|
|
|
|
–
|
|
|
Inventories
|
|
|
11,708
|
|
|
|
–
|
|
|
Prepaid expenses and other current
assets
|
|
|
237,635
|
|
|
|
195,369
|
|
|
Total
current assets
|
|
|
922,296
|
|
|
|
1,694,558
|
|
|
|
|
|
|
|
|
|
|
|
|
Property, plant
and equipment, net
|
|
|
1,120,911
|
|
|
|
378,946
|
|
|
License agreement,
net
|
|
|
5,650,988
|
|
|
|
6,267,460
|
|
|
Other assets,
net
|
|
|
346,073
|
|
|
|
392,208
|
|
|
TOTAL
ASSETS
|
|
$
|
8,040,268
|
|
|
$
|
8,733,172
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
STOCKHOLDER'S EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
|
|
|
|
Accounts payable and accrued
expenses
|
|
$
|
1,472,519
|
|
|
$
|
1,385,311
|
|
|
Loan
payable
|
|
|
50,000
|
|
|
|
50,000
|
|
|
License agreement payable, current
portion
|
|
|
|
|
|
|
|
|
|
(net
of unamortized discount of $375,467 and $71,270)
|
|
|
624,533
|
|
|
|
928,730
|
|
|
Accrued dividends on preferred
stock
|
|
|
1,078,003
|
|
|
|
765,369
|
|
|
Common
stock warrant liability and antidilution obligation
|
|
|
110,874
|
|
|
|
-
|
|
|
Total
current liabilities
|
|
|
3,335,929
|
|
|
|
3,129,410
|
|
|
|
|
|
|
|
|
|
|
|
|
License agreement
payable
|
|
|
|
|
|
|
|
|
|
(net
of unamortized discount of $622,274 and $1,464,132)
|
|
|
3,377,726
|
|
|
|
3,535,868
|
|
|
Deferred
rent
|
|
|
324,409
|
|
|
|
–
|
|
|
Total
liabilities
|
|
|
7,038,064
|
|
|
|
6,665,278
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitments and
contingencies
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders'
equity:
|
|
|
|
|
|
|
|
|
|
Preferred stock; $0.001 par value;
9,450,000 shares authorized; no shares issued and outstanding at
December 31, 2009 and 2008
|
|
|
-
|
|
|
|
-
|
|
|
Series
A Cumulative Convertible Preferred Stock; $0.001 par value; $100.00
stated value; 300,000 shares authorized, 18,400 and 26,400 shares
issued and outstanding as of December 31, 2009 and 2008,
respectively; aggregate liquidation preference of
$2,264,328
|
|
|
710,970
|
|
|
|
1,020,087
|
|
|
Series
B Cumulative Convertible Preferred Stock; $0.001 par value; $100.00
stated value; 250,000 shares authorized, 45,785 and 72,126 shares
issued and outstanding as of December 31, 2009 and 2008,
respectively; aggregate liquidation preference of
$5,232,234
|
|
|
3,094,872
|
|
|
|
5,023,429
|
|
|
Common
stock; $0.001 par value; 100,000,000 shares authorized; 31,711,578
and 19,299,168 shares issued and outstanding as of December 31,
2009 and 2008, respectively
|
|
|
31,712
|
|
|
|
19,299
|
|
|
Additional paid-in-capital
|
|
|
47,593,489
|
|
|
|
29,889,220
|
|
|
Accumulated deficit
|
|
|
(50,428,839)
|
|
|
|
(33,884,141)
|
|
|
Total
stockholders' equity
|
|
|
1,002,204
|
|
|
|
2,067,894
|
|
|
TOTAL
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
$
|
8,040,268
|
|
|
$
|
8,733,172
|
|
|
The accompanying
notes are an integral part of these consolidated financial
statements.
|
|
|
|
|
|
|
|
|
|
|
NEW GENERATION BIOFUELS HOLDINGS, INC.
Consolidated Statements of Operations
|
|
|
|
|
|
For the Three
Months Ended December 31, 2009
(Unaudited)
|
|
For the
Three
Months Ended
December 31, 2008
(Unaudited)
|
|
For the Year Ended
December 31, 2009
|
|
For the Year Ended
December 31, 2008
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
Product
|
$
|
73,644
|
$
|
22,943
|
$
|
137,532
|
$
|
22,943
|
|
|
Alternative fuel tax credit
(1)
|
|
28,246
|
|
-
|
|
41,406
|
|
-
|
|
|
|
Total revenues
|
|
101,890
|
|
22,943
|
|
178,938
|
|
22,943
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
Cost of product revenue (including
depreciation and amortization for the three months and years ended
December 31, 2009 and 2008 of $174,524, $685,806, $193,471 and
$193,471, respectively)
|
|
920,336
|
|
307,541
|
|
2,311,576
|
|
307,541
|
|
|
Research and development
|
|
111,853
|
|
246,178
|
|
475,013
|
|
1,086,723
|
|
|
General and administrative
|
|
2,975,258
|
|
3,865,493
|
|
9,751,064
|
|
9,653,380
|
|
|
Legal Settlement
|
|
-
|
|
-
|
|
-
|
|
359,595
|
|
|
License impairment charge
|
|
-
|
|
1,600,369
|
|
-
|
|
1,600,369
|
|
|
|
Total operating expenses
|
|
4,007,447
|
|
6,019,581
|
|
12,537,653
|
|
13,007,608
|
|
Loss from operations
|
|
(3,905,557)
|
|
(5,996,638)
|
|
(12,358,715)
|
|
(12,984,665)
|
|
Interest income
|
|
507
|
|
2,304
|
|
3,458
|
|
29,418
|
|
Interest expense
|
|
(198,969)
|
|
(113,823)
|
|
(537,661)
|
|
(536,581)
|
|
Other income (1)
|
|
-
|
|
7,208
|
|
-
|
|
7,208
|
|
Gain on debt extinguishment
|
|
-
|
|
-
|
|
241,500
|
|
-
|
|
(Loss) gain on net change in fair
value of derivative liabilities
|
|
(616,106)
|
|
29,452
|
|
(1,745,383)
|
|
(717)
|
|
Net loss
|
|
|
(4,720,125)
|
|
(6,071,497)
|
|
(14,396,801)
|
|
(13,485,337)
|
|
Dividends to Preferred
stockholders
|
|
(141,639)
|
|
(213,116)
|
|
(4,691,380)
|
|
(3,689,317)
|
|
Net loss attributable to common
stockholders
|
$
|
(4,861,764)
|
$
|
(6,284,613)
|
$
|
(19,088,181)
|
$
|
(17,174,654)
|
|
Basic and diluted net loss per
share
|
$
|
(0.16)
|
$
|
(0.33)
|
$
|
(0.73)
|
$
|
(0.92)
|
|
Weighted average number of shares
outstanding
|
|
29,732,892
|
|
19,143,028
|
|
26,236,636
|
|
18,725,312
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 - In 2008, revenue
from the alternative fuel tax credit was recorded as Other
income.
The accompanying
notes are an integral part of these consolidated financial
statements.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NEW GENERATION BIOFUELS HOLDINGS, INC.
Consolidated
Statement of Cash Flows
|
|
|
|
For the Year
Ended
December
31, 2009
|
|
|
For the Year
Ended
December 31, 2008
|
|
|
CASH FLOWS FROM
OPERATING ACTIVITIES:
|
|
|
|
|
|
|
|
Net
loss
|
|
$
|
(14,396,801)
|
|
|
$
|
(13,485,337)
|
|
|
Adjustments to
reconcile net loss to net cash used in operating
activities:
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
expense
|
|
|
91,951
|
|
|
|
7,383
|
|
|
Loss
on disposal of property and equipment
|
|
|
70,974
|
|
|
|
–
|
|
|
Amortization of license
agreement
|
|
|
616,472
|
|
|
|
193,471
|
|
|
Amortization of license agreement
payable discount
|
|
|
537,661
|
|
|
|
536,581
|
|
|
Compensation expense associated with
stock, stock options, and restricted stock
|
|
|
3,293,318
|
|
|
|
3,268,363
|
|
|
Compensation expense associated with
accrued stocks and warrants
|
|
|
–
|
|
|
|
124,732
|
|
|
Stock
options issued to non-employees for services
|
|
|
35,684
|
|
|
|
637,005
|
|
|
Penalty share expense
|
|
|
–
|
|
|
|
230,277
|
|
|
Warrant expense related to legal
settlement
|
|
|
–
|
|
|
|
359,595
|
|
|
Loss
on net change in fair value of derivative liabilities
|
|
|
1,745,383
|
|
|
|
717
|
|
|
Gain
on debt extinguishment
|
|
|
(241,500)
|
|
|
|
–
|
|
|
Amortization of prepaid consulting
fee
|
|
|
662,323
|
|
|
|
–
|
|
|
License impairment
|
|
|
–
|
|
|
|
1,600,369
|
|
|
Bad
debt expense
|
|
|
7,208
|
|
|
|
–
|
|
|
|
|
|
|
|
|
|
–
|
|
|
Changes in operating assets and
liabilities:
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(40,957)
|
|
|
|
(22,943)
|
|
|
Other
receivables
|
|
|
(41,406)
|
|
|
|
–
|
|
|
Inventories
|
|
|
(11,708)
|
|
|
|
–
|
|
|
Prepaid expenses and other current
assets
|
|
|
29,073
|
|
|
|
(110,401)
|
|
|
Other
assets
|
|
|
15,227
|
|
|
|
(264,136)
|
|
|
Accounts payable and accrued
expenses
|
|
|
211,941
|
|
|
|
625,996
|
|
|
Deferred rent
|
|
|
324,409
|
|
|
|
–
|
|
|
Net
cash used in operating activities
|
|
|
(7,090,748)
|
|
|
|
(6,298,328)
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM
INVESTING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
–
|
|
|
Purchase of
property and equipment
|
|
|
(881,190)
|
|
|
|
(386,329)
|
|
|
Payment for
patents
|
|
|
–
|
|
|
|
(128,072)
|
|
|
Net
cash used in investing activities
|
|
|
(881,190)
|
|
|
|
(514,401)
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM
FINANCING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
Payments for
license agreement payable
|
|
|
–
|
|
|
|
(1,000,000)
|
|
|
Net proceeds from
the issuance of common stock
|
|
|
7,063,339
|
|
|
|
–
|
|
|
Net proceeds from
the issuance of preferred stock
|
|
|
–
|
|
|
|
7,187,650
|
|
|
Proceeds from the
exercise of warrants
|
|
|
–
|
|
|
|
457,180
|
|
|
Net
cash provided by financing activities
|
|
|
7,063,339
|
|
|
|
6,644,830
|
|
|
|
|
|
|
|
|
|
|
|
|
Net decrease in
cash and cash equivalents
|
|
|
(908,599)
|
|
|
|
(167,899)
|
|
|
Cash and cash
equivalents at beginning of year
|
|
|
1,476,246
|
|
|
|
1,644,145
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash
equivalents at end of year
|
|
$
|
567,647
|
|
|
$
|
1,476,246
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying
notes are an integral part of these consolidated financial
statements.
|
|
|
|
|
|
|
|
|
|
|
|
|
Media Contact: Phil Wallis ph: (321)
363-5113
|
IR Contact: Rob Schatz Rob@wolfeaxelrod.com
|
|
Or
pjwallis@newgenerationbiofuels.com
|
|
|
|
|
|
|
SOURCE New Generation Biofuels Holdings, Inc.